| Source | : | RHB-OSK | ||||||||
| Stock | : | PRLEXUS | Price Target | : | 3.15 | | | Price Call | : | TRADING BUY | |
| Last Price | : | 2.59 | | | Upside/Downside | : |  +0.56 (21.62%) | ||||
Last month, the 30-stock FBMKLCI managed to reverse its downtrend with a technical rebound on the last day of the month to clinch a 1.0% MoM gain despite concerns arising from a cabinet reshuffling, ringgit hitting a low of RM3.83, and the on-going 1MDB saga. Going forward, the market is expected to range-bound within 1,685-1,750 in the near term while awaiting fresh catalysts. As we are entering the 2QCY15 reporting season, we believe attention will again revert to quarterly corporate results, more so as the current reporting quarter is the first full quarter post-GST implementation. Meanwhile, our OR tracker portfolio also moved in tandem with the benchmark index, capturing a MoM growth of 3.1% last month. The portfolio’s total return continues to beat the market on both YTD basis (11.3% vs. -0.69%) as well as since its inception (28.8% vs. 14.9%).
Four Trading Buys. In July, we kept our idea momentum in full force and released a total of seven OR reports, including three new trading ideas (PWROOT TP: RM2.58, PRLEXUS, TP: RM3.15 and SUNCON, TP: RM1.40), one upgraded call (SASBADI, TP: RM2.68) and two NOT-RATED pieces (FIAMMA and FAVCO). We added two consumer stocks, namely PWROOT and PRLEXUS into our OR tracker list due to their attractive valuations and solid business fundamentals, catering for investors seeking exposure to defensive and resilience sectors. Similarly, we have upgraded SASBABI to TRADING BUY from NOT-RATED with TP of RM2.68 on the back of its stable EBITDA margins of c.25% and favourable earnings growth prospect of 14%- 29% for FY15-FY16. On the other hand, we decided to Take Profit on PIE which, in our view, was trading in line with the industry average valuation and bagged a gain of c.45% within two years.
http://klse.i3investor.com/servlets/ptres/31499.jsp
没有评论:
发表评论